The trajectory of the erectile dysfunction drug presents a challenging picture for those considering investment. While the initial release generated substantial returns, the lapse of its patent opened the floodgates to https://karimswfx553613.idblogz.com/42154413/sildenafil-and-the-pharmaceutical-industry-a-precarious-opportunity